On November 26, 2024 Bristol Myers Squibb (NYSE: BMY) reported that the company will participate in Citi’s 2024 Global Healthcare Conference (Press release, Bristol-Myers Squibb, NOV 26, 2024, View Source [SID1234648652]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Christopher Boerner, Ph.D., board chair and chief executive officer, will take part in a fireside chat on December 3, 2024. He will answer questions about the company beginning at 8:00 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session by visiting View Source An archived edition of this session will be available following its conclusion.

On November 26, 2024 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., reported it will participate in fireside chats at two upcoming investor conferences (Press release, BeiGene, NOV 26, 2024, View Source [SID1234648651]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citizens JMP Hematology and Oncology Summit on Monday, December 2 at 1:00 p.m. ET; and
Citi’s Global Healthcare Conference on Thursday, December 5 at 9:30 a.m. ET

The live webcasts of these events can be accessed from the investors section of BeiGene’s website at View Source, View Source, View Source An archived replay will be available for 90 days following the event.

On November 26, 2024 ALX Oncology Holdings Inc., ("ALX Oncology" or "the Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients’ lives, reported that Jason Lettmann, the Company’s Chief Executive Officer will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference being held in New York City from December 3-5, 2024 (Press release, ALX Oncology, NOV 26, 2024, View Source [SID1234648649]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Format: Fireside chat with analyst, Christopher Raymond and 1×1 meetings
Date: Tuesday, December 3, 2024
Time: 9:30 AM EST
Location: New York City, NY
Webcast link: Available here

The live webcast for the Piper Sandler fireside chat can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcast will be archived for up to 90 days following the fireside chat date.

On November 26, 2024 Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, reported that members of management will present at two investor conferences being webcast in December (Press release, Aligos Therapeutics, NOV 26, 2024, View Source [SID1234648648]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 36th Annual Healthcare Conference
Fireside Chat at 11:00am ET/8:00am PT on December 3, 2024
Evercore ISI 7th Annual HealthCONx Conference
Fireside Chat at 4:15pm ET/1:15pm PT on December 3, 2024

In addition to the presentations, management will participate in one-on-one meetings. A live webcast of each event will be accessible by visiting the "Investors" page of Aligos’ website at www.aligos.com. A replay of the webcasts will be available following the presentation for at least 30 days.

On November 26, 2024 Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, reported that members of the Aclaris management team will participate in a fireside chat during the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 1:00 PM ET in New York, New York (Press release, Aclaris Therapeutics, NOV 26, 2024, View Source [SID1234648647]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A webcast of the fireside chat may be accessed through the "Events" page of the "Investors" section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.